APA (7th ed.) Citation

Habeichi, N. J., Amin, G., Boitard, S., Tannous, C., Ghali, R., Momken, I., . . . Zouein, F. A. Nicotinamide Riboside: A Promising Treatment for Type 1 Cardiorenal Syndrome in Myocardial Infarction‐Induced Acute Kidney Injury by Upregulating Nicotinamide Phosphoribosyltransferase‐Mediated Nicotinamide Dinucleotide Levels. Wiley.

Chicago Style (17th ed.) Citation

Habeichi, Nada J., et al. Nicotinamide Riboside: A Promising Treatment for Type 1 Cardiorenal Syndrome in Myocardial Infarction‐Induced Acute Kidney Injury by Upregulating Nicotinamide Phosphoribosyltransferase‐Mediated Nicotinamide Dinucleotide Levels. Wiley.

MLA (9th ed.) Citation

Habeichi, Nada J., et al. Nicotinamide Riboside: A Promising Treatment for Type 1 Cardiorenal Syndrome in Myocardial Infarction‐Induced Acute Kidney Injury by Upregulating Nicotinamide Phosphoribosyltransferase‐Mediated Nicotinamide Dinucleotide Levels. Wiley.

Warning: These citations may not always be 100% accurate.